The objectives are (1) to compare primaquine plus chloroquine with chloroquine alone for preventing relapses in people with P. vivax malaria; and (2) to compare primaquine of any dosage or duration with the standard primaquine regimen of 15 mg/day for 14 days for preventing relapses in people with P. vivax malaria.
Galappaththy, G.N.L.; Omari, A.A.A. Primaquine for preventing relapses in people with Plasmodium vivax malaria. Cochrane Database of Systematic Reviews (2003) Issue 3, Art. No.: CD004389. [DOI: 10.1002/14651858.CD004389]